Josh Gelman, a multi-award-winning producer for CBS News 48 Hours died Tuesday evening, January 4, at the age of 62, after a long, courageous battle with cancer. His wife Christina, his brothers Gregg and Matt, and Greggs husband Joe were at his side.
Josh Gelman/Facebook
In his nearly three-decade career at CBS News, Josh displayed his numerous talents as an editor, producer, writer, and photographer. His supreme gift was finding, capturing, and deploying images that revealed the emotion and deeper meanings at the heart of every story. And his stories took him seemingly everywhere: from covering the Eco-Challenge race in Borneo; to exploring the inner workings of Hollywood; to reporting on some of the worlds most compelling true-crime sagas such as the disappearance of Madeleine McCann, the murder of Martha Moxley, the trial of Jodi Arias and the case of Fatal Vision killer Jeffrey MacDonald.
Josh was also beloved as a colleague who always took the time to mentor, to teach, to help. Years since they last worked with Josh, many producers and editors across the industry still regard the time they spent with him as a pivotal moment in their career.
Josh truly understood the power of storytelling. And it was a story that changed his life forever.
Josh Gelman/Facebook
In 1998, Josh began documenting the journey of a 12-year-old girl named Colby who was being treated for leukemia. He spent a great deal of time with Colby and formed a lasting bond with her family.
The experience made a deep impression on me, he later said.
Josh stayed in touch with Colbys family, even after she died the following summer. He was so moved by his experience with her that he became a regular platelet donor, on the chance that he could save someone elses life. Nine years later, Josh was preparing to give platelets at Memorial Sloan Kettering Hospitals blood donor room when he got an inkling that something might be wrong with his own blood.
They plugged me into the machine and then unplugged me right away, Josh later recalled. A doctor came in and said, You need to see a hematologist.'
Josh was diagnosed with essential thrombocythemia, a condition involving the blood and marrow. It was treatable with medication, but there was a chance the condition could progress. Unfortunately, it did.
In 2014, Josh was diagnosed with a rare disorder called myelofibrosis, which can develop into leukemia. He needed new stem cells from a bone marrow transplant, but there were no matches. With the clock ticking, he was treated by Dr. Juliet Barker, a leading expert in cord blood transplants, which use stem cells from the umbilical cord and placenta of healthy newborns. It was a relatively new approach for a diagnosis like Joshs, and Dr. Barkers team performed the procedure on him in January of 2015.
It would be a long road back, but Joshs wide circle of family and friends, including his colleagues at CBS News and 48 Hours, were with him on the journey.
In the beginning, there were small victories, frequent setbacks, and many difficult days. But Josh, an avid sportsman and extreme athlete, was up for the challenge.
Im a strong believer in taking things one step at a time, he said. I just told myself that all I have to do is take the next step. I never worried about how I was going to get over the finish line.
In 2017, Josh crossed more than one finish line.
Josh Gelman/Facebook
In May, he completed the Brooklyn Half Marathon in two-and-a-half hours. That same year he married Christina Leijonhufvud, the CEO of BlueMark, an impact investment company. Josh also became a beloved father to Christinas daughter, Eva.
Josh Gelman/Facebook
Josh remained grateful to his medical team and was committed to helping them save the lives of others. He rode in Cycle for Survival to raise money for rare cancer research at Memorial Sloan Kettering. This was on top of the years he spent as an athlete and coach with Team in Training, an organization that uses endurance sports competition to raise money for the Leukemia and Lymphoma Society. Numerous cancer survivors and others credit Joshs coaching with helping them complete races that they never dreamed of even competing in.
Josh Gelman/Facebook, MSKCC.org
And Josh made time in his busy, active life to resume his fly fishing pilgrimages to Montana, to celebrate each and every milestone with Christina, and to teach Eva to rock climb.
MSKCC.org
In the years after his recovery, Josh did some of the finest work of his career at CBS News. Most notably, he served as a senior producer on Bravery and Hope: 7 Days on The Front Line. This award-winning documentary featured the work of a team of CBS News journalists embedded with emergency physicians and critical care specialists, struggling to save patients suffering from COVID-19 at Montefiore Medical Center in the Bronx at the height of the pandemic.
Bravery and Hope: two words that defined Josh Gelman.
In November of 2020, Josh shared a note with the 48 Hours staff that after six years, his cancer was back, despite his successful stem cell transplant. Josh shared his news, he said, because he thought it might help someone.
I always feel its better to share this stuff as you never know who else I could help with my experience or find help with someone elses, he wrote. Though this is another mountain to climb, Im so lucky to have my family friends and co-workers to get me up that hill. We are feeling optimistic, I am strong, and I take great comfort that I have the people in my life that I do.
Josh climbed that mountain, with his family, friends and colleagues behind him, until he succumbed this past Tuesday. While his loss is felt deeply, many reflected admiringly on his achievements, his countless acts of kindness and friendship, and his courage.
Josh was the bravest person I have ever known quietly fighting cancer. Never saying much about it, said 48 Hours executive producer Judy Tygard. Just pushing on.
In addition to his wife, Christina, and his daughter, Eva, Josh is survived by his mother, Joan Gelmana former writer and producer at CBS News his father Warren Gelman, his stepmother Susan Gelman, his brothers and sisters Gregg Gelman and Joseph Hershberger, Wendy and Rhys Gwyn, Matt and Meredith Gelman, Herbie and Kalle Gelman, Nancy and Eric Chilton, and Helaine and John Winer, and nieces and nephews Gracie, Lindsay, Jack, Alexa, Ryan, Jake, Hunter, and Olivia.
Donations can be made in Joshs honor to Memorial Sloan Ketterings Cycle for Survival.
Follow this link:
Josh Gelman, CBS News producer who embodied bravery, hope, dies of cancer - WSGW
- Embattled Cordlife receives letter of demand from client for breach of contract - The Straits Times - May 4th, 2024
- From Cord Blood to Microbiome; The evolution of Rotary's gift to the people of WA - Lifeblood - May 2nd, 2024
- Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune ... - Nature.com - April 28th, 2024
- Hitting the pavement for cord blood research | Cranbourne Star News - Cranbourne Star News - April 28th, 2024
- One year to test 200 Cordlife samples 'totally unjustified': Global cord blood banking experts - The Straits Times - April 15th, 2024
- Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells - Medical Xpress - April 7th, 2024
- The umbilical cord: a rich and ethical stem cell source to advance ... - March 30th, 2024
- Story of discovery: getting a Notch up on cord blood cell ... - March 30th, 2024
- Cord Blood Transplants | Memorial Sloan Kettering Cancer Center - March 30th, 2024
- Therapeutic effect and study of human umbilical cord blood mononuclear cells in patients with ischaemic bowel ... - Nature.com - March 17th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024: The Vast Majority of the Global Cord Blood Market is Now ... - PR Newswire - March 15th, 2024
- Improving Transplant Outcomes and Cell Therapy Approaches - RegMedNet - March 9th, 2024
- The inhibition of ADAM17 in cord blood stem cell-derived CD16+ NK cells to enhance their cytotoxicity against acute ... - ScienceDirect.com - March 1st, 2024
- Beating Blood Cancer through Recycling - a Community crowdfunding project in Liverpool by Kate Williams - Crowdfunder UK - February 24th, 2024
- Cord Blood Registry (CBR ) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - Investing.com Canada - February 9th, 2024
- Young cancer patient with 'no hope' of recovery saved by baby's umbilical cord - Study Finds - February 9th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN - January 26th, 2024
- Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation - Medical Xpress - January 26th, 2024
- Cord Blood Banking Market Sales and Revenue Report 2023-2032 - WhaTech Technology and Markets News - January 26th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN USA - January 24th, 2024
- Global Biobanking Market Size To Exceed USD 97.5 Billion By 2032 | CAGR of 5.8% - GlobeNewswire - January 24th, 2024
- The use of cryopreservation in life saving research - The Manufacturer - January 24th, 2024
- CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies - Medical Xpress - January 18th, 2024
- Cord blood banking comes at a high cost to babies - STAT - STAT - January 18th, 2024
- Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances - PR Newswire - January 16th, 2024
- Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering - January 11th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 4th, 2024
- askST: Can cord blood units be transferred from one bank to another? - The Straits Times - December 27th, 2023
- Timeline: Cordlife's mishandling of cord blood units in Singapore - CNA - December 15th, 2023
- Next-Level Evolution: Enhancing the Human Body With Anthrobots ... - Securities.io - December 5th, 2023
- Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ... - Fred Hutchinson Cancer Center - December 5th, 2023
- Enhancing the immunosuppressive properties of human umbilical ... - Phys.org - December 1st, 2023
- Global Status and Trends for Thromboangiitis Obliterans | JPR - Dove Medical Press - December 1st, 2023
- Early Stage Cell Therapy Trial Shows Promise in Treating Progressive Multiple Sclerosis - University of Colorado Anschutz Medical Campus - December 1st, 2023
- Global Medical Specialty Bag Market is Expected to Reach US$ 9.4 Billion by 2034, Rising at a Steady 4.7% CAGR | Future Market Insights, Inc. - Yahoo... - November 29th, 2023
- Repeated concussions can alter heart activity and impact the heart ... - Philippine Canadian Inquirer - November 29th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - PharmiWeb.com - November 27th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - Marketscreener.com - November 25th, 2023
- FY 2021 VA-Funded Projects - VA's Office of Research and Development - November 25th, 2023
- New study aims to expand access to stem cell transplant using ... - Healio - November 23rd, 2023
- Impact of GVHD Prophylaxis on CMV Reactivation and Disease ... - Cancer Network - November 23rd, 2023
- The Top 25 Women Leaders in Biotechnology of 2023 - The Healthcare Technology Report. - November 21st, 2023
- First Edition: November 20, 2023 - KFF Health News - November 21st, 2023
- An essential guide to the building blocks of life - Gates Notes - November 21st, 2023
- A Simple Way to Save Premature Babies - The New York Times - November 19th, 2023
- Perspectives of current understanding and therapeutics of Diamond ... - Nature.com - November 17th, 2023
- Brain Organoids: Should They Be Considered People? - BBVA OpenMind - November 17th, 2023
- Understanding the cause of childhood Alzheimer's - ASBMB Today - November 17th, 2023
- Peripheral nerve regeneration through nanofiber scaffolds | IJN - Dove Medical Press - November 15th, 2023
- Are STEM CELL EXOSOMES the secret to a 'snatched' jawline? Discover the products that influencers are claiming - Daily Mail - November 13th, 2023
- CAR-NK: The next generation in hematological malignancy treatment - News-Medical.Net - November 13th, 2023
- Regenerative Medicine | Top Regenerative Medicine Solution ... - Healthcare Tech Outlook - November 13th, 2023
- Stem cell therapy, emerging solution to slow down ageing - Punch Newspapers - November 13th, 2023
- Improving Cord Blood Transplantation Outcomes for Adults With ... - On Cancer - Memorial Sloan Kettering - November 11th, 2023
- 8 Ways To Save Lives With Canadian Blood Services & You Can ... - Narcity Canada - November 11th, 2023
- Internal investigation by Vita 34 AG reveals irregularities related to a ... - Marketscreener.com - November 11th, 2023
- 'We worried the worst would happen' - Yorkshire Children's Trust ... - The Yorkshire Post - November 11th, 2023
- Minor GPI(-) granulocyte populations in aplastic anemia and healthy ... - Nature.com - November 9th, 2023
- Repeated treatment with ProTrans is immunologically safe ... - Marketscreener.com - November 7th, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells - Benzinga - November 7th, 2023
- Health Canada issues warning on cord blood stored in Edmonton - CBC News - November 3rd, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting - Yahoo... - November 3rd, 2023
- Dynamic Stem Cell Therapy Uncovers Research in Advance ... - InvestorsObserver - November 3rd, 2023
- Go with the flow and achieve hearing restoration - Drug Discovery News - November 3rd, 2023
- Cell Therapy Market to Witness Exponential Growth by 2031 ... - Argyle Report - November 1st, 2023
- Cross-talk between Myeloid and B Cells Shapes the Distinct ... - Cancer Discovery - November 1st, 2023
- Comparison of effects of HucMSCs, exosomes, and conditioned ... - Nature.com - October 28th, 2023
- The structural and functional complexity of the integrative ... - Science - October 28th, 2023
- Global Primary Cells Market to Witness Growth at 11.41% CAGR to ... - GlobeNewswire - October 26th, 2023
- Hma-Qubec celebrates 25 years of giving life in anniversary ad - - The Message - October 26th, 2023
- Improvement of thermal-stability of chondroitinase ABCI immobilized ... - Nature.com - October 26th, 2023
- Sydney Couple Overcomes Sperm Antibody Issue to Welcome Baby - OPP.Today - October 24th, 2023
- New Research Reveals Surprising Issue with Sperm and Fertility - CityLife - October 24th, 2023
- Biobanking Market to Observe Prominent CAGR of 6.10% by 2029 ... - PharmiWeb.com - October 21st, 2023
- TV shows like BBC's Call The Midwife and C4's One Born Every Minute 'are inaccurately depicting childbirth' an - Daily Mail - October 19th, 2023
- Advances in medical and technological research and SCI - Clyde & Co - October 18th, 2023
- Prognostic Value of Hematogones in Patients With Hematopoietic ... - Cureus - October 18th, 2023
- Stem-Cell Therapy: Filling Gaps in Oro-Maxillofacial Region - Cureus - October 18th, 2023
- The neonatal southern white rhinoceros ovary contains oogonia in ... - Nature.com - October 18th, 2023
- OMG: Sperm injury led to rare baby struggle - news.com.au - October 18th, 2023
Recent Comments